Oct. 3 (UPI) -- The Trump administration this week approved a second generic abortion pill despite opposition from Republicans and anti-abortionists.
The Food and Drug Administration approved the mifepristone drug by Evita Solutions on Tuesday, though there was no official announcement.
This is the second generic abortion pill to be approved by the FDA, with Mifeprex, the original brand-name mifepristone pill, receiving approval back in 2000.
Mifepristone has gained more attention in the United States since June 2022, when the conservative-leaning Supreme Court removed federal protections for access to abortion with the overturning of the landmark 1973 Roe vs. Wade ruling.
While President Donald Trump said during his campaign that he would ensure the FDA would not block access to abortion pills, he has been under pressure to restrict access to it by Republicans and anti-abortion activists.
